Predict your next investment

Corporation
HEALTHCARE | Medical Devices & Equipment
courtagen.com

See what CB Insights has to offer

Total Raised

$35.12M

Investors Count

6

Deal Terms

2

Courtagen Life Sciences Funding, Courtagen Life Sciences Valuation & Courtagen Life Sciences Revenue

5 Fundings

Courtagen Life Sciences's latest funding round was a Series C for $20M on June 16, 2015.

Courtagen Life Sciences's valuation in October 2011 was $39.81M.

Courtagen Life Sciences's latest post-money valuation is from October 2011.

Sign up for a free trial to see Courtagen Life Sciences's valuations in August 2010 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

6/16/2015

Series C

$20M

4

6/19/2014

Option/Warrant

$99M

10

2/17/2012

Grant

$99M

0

10/7/2011

Series B

$99M

$39.81M

10

8/23/2010

Series A

$99M

$99M

0

Date

6/16/2015

6/19/2014

2/17/2012

10/7/2011

8/23/2010

Round

Series C

Option/Warrant

Grant

Series B

Series A

Amount

$20M

$99M

$99M

$99M

$99M

Investors

Valuation

$39.81M

$99M

Revenue

Sources

4

10

0

10

0

Courtagen Life Sciences Deal Terms

2 Deal Terms

Courtagen Life Sciences's deal structure is available for 2 funding rounds, including their Series B from October 07, 2011.

Round

Series B

Series A

Funding Date

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

Courtagen Life Sciences Investors

6 Investors

Courtagen Life Sciences has 6 investors. Harbor Light Capital Partners invested in Courtagen Life Sciences's Series C funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

10/7/2011

6/16/2015

2
Series B, Series C (2015)

Venture Capital

New Hampshire

00/00/0000

00/00/0000

Bunker Hill Capital

Subscribe to see more

Private Equity

Massachusetts

00/00/0000

00/00/0000

First Analysis

Subscribe to see more

Venture Capital

Illinois

00/00/0000

00/00/0000

Adler & Co.

Subscribe to see more

Corporation

Colorado

00/00/0000

00/00/0000

Massachusetts Life Sciences Center

Subscribe to see more

Public-Private Partnership

Massachusetts

First funding

10/7/2011

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

6/16/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Bunker Hill Capital

First Analysis

Adler & Co.

Massachusetts Life Sciences Center

Rounds

2
Series B, Series C (2015)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Private Equity

Venture Capital

Corporation

Public-Private Partnership

Location

New Hampshire

Massachusetts

Illinois

Colorado

Massachusetts

Courtagen Life Sciences Acquisitions

2 Acquisitions

Courtagen Life Sciences acquired 2 companies. Their latest acquisition was Medicinal Genomics on January 19, 2012.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/19/2012

Other

$99M

$7.68M

Acquired

1/6/2010

Series A

Subscribe to see more

$99M

$99M

Subscribe to see more

10

Date

1/19/2012

1/6/2010

Investment Stage

Other

Series A

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

$7.68M

$99M

Note

Acquired

Subscribe to see more

Sources

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.